| BMS Partners with Repare on Synthetic Lethal Target Discovery for US$65 M Upfront |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Gilead Continues Oncology Spree with US$2.2 B Arcus Deal |
Abstract
pdf
html
|
|
Michelle Liu |
|
| AstraZeneca Signs US$1.2 B RNA Modification Partnership with Accent Therapeutics |
Abstract
pdf
html
|
|
Michelle Liu |
|
| AbbVie Commits US$750 M Upfront to Oncology Collaboration with Genmab |
Abstract
pdf
html
|
|
Michelle Liu |
|
| GlaxoSmithKline Signs US$3 B Synthetic Lethality Alliance with IDEAYA Biosciences |
Abstract
pdf
html
|
|
Michelle Liu |
|
| Novo Nordisk Acquires Cardio-Renal Focused Corvidia Therapeutics |
Abstract
html
pdf
|
|
Michelle Liu |
|
